Philippe Armand, MD, PhD, senior physician, Dana-Farber Cancer Institute, discusses the utility of PD-1 inhibitors for hematologic malignancies.
Philippe Armand, MD, PhD
Articles by Philippe Armand, MD, PhD
Latest Updated Articles
PD-1 Inhibitors for Hematologic MalignanciesPublished: December 7th 2014 | Updated: September 11th 2023